These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12615652)

  • 1. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment.
    Kanai K; Kuwabara S; Arai K; Sung JY; Ogawara K; Hattori T
    Brain; 2003 Apr; 126(Pt 4):965-73. PubMed ID: 12615652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle excitability abnormalities in Machado-Joseph disease.
    França MC; D'Abreu A; Nucci A; Lopes-Cendes I
    Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of mexiletine on excitability properties of human median motor axons.
    Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor nerve hyperexcitability and muscle cramps in Machado-Joseph disease.
    Kanai K; Kuwabara S
    Arch Neurol; 2009 Jan; 66(1):139; author reply 139-40. PubMed ID: 19139316
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.
    Tamura N; Kuwabara S; Misawa S; Kanai K; Nakata M; Sawai S; Hattori T
    Clin Neurophysiol; 2006 Nov; 117(11):2451-8. PubMed ID: 16996798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor and extracerebellar features in Machado-Joseph disease: a review.
    Pedroso JL; França MC; Braga-Neto P; D'Abreu A; Saraiva-Pereira ML; Saute JA; Teive HA; Caramelli P; Jardim LB; Lopes-Cendes I; Barsottini OG
    Mov Disord; 2013 Aug; 28(9):1200-8. PubMed ID: 23775899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitability properties of motor axons in patients with spontaneous motor unit activity.
    Kiernan MC; Hart IK; Bostock H
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):56-64. PubMed ID: 11118248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy.
    Farrar MA; Vucic S; Lin CS; Park SB; Johnston HM; du Sart D; Bostock H; Kiernan MC
    Brain; 2011 Nov; 134(Pt 11):3185-97. PubMed ID: 21926101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve excitability changes related to axonal degeneration in amyotrophic lateral sclerosis: Insights from the transgenic SOD1(G127X) mouse model.
    Moldovan M; Alvarez S; Pinchenko V; Marklund S; Graffmo KS; Krarup C
    Exp Neurol; 2012 Jan; 233(1):408-20. PubMed ID: 22116045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
    Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machado-Joseph disease presenting as motor neuron disease.
    Pinto S; De Carvalho M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):188-91. PubMed ID: 17963092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Studies in Management of Muscle Cramps.
    Katzberg HD
    Neurol Clin; 2020 Aug; 38(3):679-696. PubMed ID: 32703476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal excitability properties in amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
    Weiss MD; Macklin EA; Simmons Z; Knox AS; Greenblatt DJ; Atassi N; Graves M; Parziale N; Salameh JS; Quinn C; Brown RH; Distad JB; Trivedi J; Shefner JM; Barohn RJ; Pestronk A; Swenson A; Cudkowicz ME;
    Neurology; 2016 Apr; 86(16):1474-81. PubMed ID: 26911633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior horn degeneration in Machado-Joseph disease.
    Pedroso JL; de Resende Pinto WB; de Souza PV; Andriotti C; Stavale JN; Barsottini OG
    J Neurol Sci; 2016 Sep; 368():290-1. PubMed ID: 27538651
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of oropharyngeal dysphagia in Machado-Joseph disease.
    Corrêa SM; Felix VN; Gurgel JL; Sallum RA; Cecconello I
    Arq Gastroenterol; 2010; 47(4):334-8. PubMed ID: 21225141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disorders in Machado-Joseph disease.
    Pedroso JL; Braga-Neto P; Martinez AR; Martins CR; Rezende Filho FM; Sobreira-Neto MA; Prado LB; do Prado GF; França MC; Barsottini OG
    Curr Opin Psychiatry; 2016 Nov; 29(6):402-8. PubMed ID: 27584711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep symptoms and their clinical correlates in Machado-Joseph disease.
    D'Abreu A; França M; Conz L; Friedman JH; Nucci AM; Cendes F; Lopes-Cendes I
    Acta Neurol Scand; 2009 Apr; 119(4):277-80. PubMed ID: 18771522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of physiological fluctuation of serum potassium levels on excitability properties in healthy human motor axons.
    Kuwabara S; Misawa S; Kanai K; Tamura N; Nakata M; Sawai S; Hattori T
    Clin Neurophysiol; 2007 Feb; 118(2):278-82. PubMed ID: 17141564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.